Lupus Eritematosus Sistemik (LES) pada Kehamilan
DOI:
https://doi.org/10.35790/ecl.v9i2.35375Abstract
Abstract: Systemic lupus erythematosus (SLE) is a multi-organ autoimmune disease that can affect women of childbearing age. Pregnancy causes alterations of the immune and neuroendocrine systems. Moreover, SLE in pregnancy is associated with prematurity and preeclampsia. Confirmation of the SLE diagnosis based on anamnesis, physical examination, and laboratory results is essential to differ the similar symptoms of normal pregnancy from pregnancy with SLE, such as preeclampsia, to lupus nephritis due to differences in treatment. The management of SLE in pregnancy has begun to be well understood; therefore, immunosuppressive drugs can be administered according to the indications and fetal safety. It is essential to educate women with SLE to not get pregnant before the 6-months remission period and explain the relative contraindications to pregnancy.
Keywords: systemic lupus erythematosus; pregnancy; immunosuppressive
 Â
Abstrak: Lupus eritematosus sistemik (LES) merupakan suatu penyakit autoimun multi-organ yang dapat menyerang wanita usia reproduktif. Kehamilan menyebabkan perubahan pada sistem imun dan neuroendokrin. LES pada wanita hamil dihubungkan dengan kejadian kelahiran prematuritas dan preeklamsia. Penentuan diagnosis berdasarkan anamnesis, pemeriksaan fisik, dan pemeriksaan penunjang penting untuk membedakan gejala-gejala yang mirip pada kehamilan normal dengan kehamilan yang disertai LES seperti preeklamsia dengan lupus nefritis karena tatalaksana yang diberikan berbeda. Tatalaksana LES pada kehamilan telah mulai dipahami sehingga pemberian obat-obatan imunosupresif dapat diberikan sesuai dengan indikasi dan keamanan pada janin. Penting untuk mengedukasi wanita dengan LES untuk tidak hamil sebelum melewati masa remisi enam bulan dan menjelaskan kontraindikasi relatif pada kehamilan.
Kata kunci: lupus eritematous sistemik; kehamilan; imunosupresif
Downloads
Published
How to Cite
Issue
Section
License
COPYRIGHT
Authors who publish with this journal agree to the following terms:
Authors hold their copyright and grant this journal the privilege of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that permits others to impart the work with an acknowledgment of the work's origin and initial publication by this journal.
Authors can enter into separate or additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (for example, post it to an institutional repository or publish it in a book), with an acknowledgment of its underlying publication in this journal.
Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their website) as it can lead to productive exchanges, as well as earlier and greater citation of the published work (See The Effect of Open Access).